Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nasser Hanna, M.D.
Hoosier Oncology Group, LLC
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medical & Surgical Specialists, Llc
Galesburg, Illinois, United States
- Cancer Care Center of Southern Indiana
Bloomington, Indiana, United States
- Oncology Hematology Associates of Sw Indiana
Evansville, Indiana, United States
- Fort Wayne Oncology & Hematology, Inc
Fort Wayne, Indiana, United States
- Community Regional Cancer Center
Indianapolis, Indiana, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Quality Cancer Center (mcgop)
Indianapolis, Indiana, United States
- Arnett Cancer Care
Lafayette, Indiana, United States
- Horizon Oncology Center
Lafayette, Indiana, United States
- Medical Consultants, P.C.
Muncie, Indiana, United States
- Northern Indiana Cancer Research Consortium
South Bend, Indiana, United States
- Methodist Cancer Center
Omaha, Nebraska, United States
- Oncology Partners Network
Cincinnati, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2006
- Primary completion
- 30 Apr 2008
- Completion
- 31 Dec 2008
- Last update posted
- 11 Feb 2016
- Registered enrollment
- 25
- Registry id
- NCT00367601
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.